Predictive risk factors for coronary artery abnormalities in Kawasaki disease

European Journal of Pediatrics

Volumn 166, Issue 5, 2007, Pages 421-425

  Kim, Taeyeun ^a   Choi, WookSun ^a   Woo, Chan Wook ^a   Choi, Byungmin ^a   Lee, Junghwa ^a,b   Lee, Kwangchul ^a   Son, Changsung ^a   Lee, Joowon ^a,b  

^a Korea University College of Medicine   (South Korea)

^b Korea University Ansan Hospital   (South Korea)

Author keywords

Coronary abnormality; IVGG non responsiveness; Kawasaki disease; Risk factor

Indexed keywords

ACETYLSALICYLIC ACID; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; C REACTIVE PROTEIN; IMMUNOGLOBULIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CONFIDENCE INTERVAL; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE DURATION; DRUG MEGADOSE; FEMALE; FEVER; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MUCOCUTANEOUS LYMPH NODE SYNDROME; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREDICTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; TREATMENT RESPONSE;

CHI-SQUARE DISTRIBUTION; CHILD, PRESCHOOL; CORONARY VESSEL ANOMALIES; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT; KOREA; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PREDICTIVE VALUE OF TESTS; REGRESSION ANALYSIS; RISK FACTORS;

EID: 33947357163     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-006-0251-8     Document Type: Article

References (26)

1. Burns JC, Capparelli EV, Brown JA, Newburger JW, Glode MP (1998) Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US/Canadian Kawasaki Syndrome Study Group. Pediatr Infect Dis J 17(12):1144-1148
2. Council on Cardiovascular Disease in the Young, Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, American Heart Association (2001) Diagnostic Guidelines for Kawasaki disease. Circulation 103(2):335-336
3. Durongpisitkul K, Soongswang J, Laohaprasitiporn D, Nana A, Prachuabmoh C, Kangkagate C (2003) Immunoglobulin failure and retreatment in Kawasaki disease. Pediatr Cardiol 24(2):145-148
4. Falcini F (2006) Kawasaki disease. Curr Opin Rheumatol 18(1):33-38
5. Fujiwara T, Fujiwara H, Nakano H (1988) Pathological features of coronary arteries in children with Kawasaki disease in which coronary arterial aneurysm was absent at autopsy. Quantitative analysis. Circulation 78(2):345-350
6. Fukunishi M, Kikkawa M, Hamana K, Onodera T, Matsuzaki K, Matsumoto Y, Hara J (2000) Prediction of non-responsiveness to intravenous high-dose gamma-globulin therapy in patients with Kawasaki disease at onset. J Pediatr 137(2):172-176
7. Harada K (1991) Intravenous gamma-globulin treatment in Kawasaki disease. Acta Paediatr Jpn 33(6):805-810
8. Honkanen VE, McCrindle BW, Laxer RM, Feldman BM, Schneider R, Silverman ED (2003) Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease. Pediatr Cardiol 24(2):122-126
9. Kawamura T, Wago M, Kawaguchi H, Tahara M, Yuge M (2000) Plasma brain natriuretic peptide concentrations in patients with Kawasaki disease. Pediatr Int 42(3):241-248
10. Kurotobi S, Nagai T, Kawakami N, Sano T (2002) Coronary diameter in normal infants, children and patients with Kawasaki disease. Pediatr Int 44(1):1-4
11. Kurotobi S, Kawakami N, Shimizu K, Aoki H, Nasuno S, Takahashi K, Kogaki S, Ozono K (2005) Brain natriuretic peptide as a hormonal marker of ventricular diastolic dysfunction in children with Kawasaki disease. Pediatr Cardiol 26(4):425-430
12. Miura M, Ohki H, Tsuchihashi T, Yamagishi H, Katada Y, Yamada K, Yamashita Y, Sugaya A, Komiyama O, Shiro H (2004) Coronary risk factors in Kawasaki disease treated with additional gammaglobulin. Arch Dis Child 89(8):776-780
13. Mori M, Imagawa T, Yasui K, Kanaya A, Yokota S (2000) Predictors of coronary artery lesions after intravenous gammaglobulin treatment in Kawasaki disease. J Pediatr 137(2):177-180
14. Muta H, Ishii M, Egami K, Furui J, Sugahara Y, Akagi T, Nakamura Y, Yanagawa H, Matsuishi T (2004) Early intravenous gamma-globulin treatment for Kawasaki disease: the nationwide surveys in Japan. J Pediatr 144(4):496-499
15. Muta H, Ishii M, Furui J, Nakamura Y, Matsuishi T (2006) Risk factors associated with the need for additional intravenous gamma-globulin therapy for Kawasaki disease. Acta Paediatr 95(2):189-193
16. Nakamura Y, Oki I, Tanihara S, Ojima T, Yanagawa H (1998) Cardiac sequelae in recurrent cases of Kawasaki disease: a comparison between the initial episode of the disease and a recurrence in the same patients. Pediatrics 102(6):E66
17. Nakamura Y, Yashiro M, Uehara R, Watanabe M, Tajimi M, Oki I, Ojima T, Sonobe T, Yanagawa H (2004) Use of laboratory data to identify risk factors of giant coronary aneurysms due to Kawasaki disease. Pediatr Int 46(1):33-38
18. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert K (2004) A Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young. American Heart Association. Circulation 110(17):2747-2771
19. Noto N, Okada T, Yamasuge M, Taniguchi K, Karasawa K, Ayusawa M, Sumitomo N, Harada K (2001) Noninvasive assessment of the early progression of atherosclerosis in adolescents with Kawasaki disease and coronary artery lesions. Pediatrics 107(5):1095-1099
20. Oki I, Tanihara S, Ojima T, Nakamura Y, Yanagawa H (2000) A multicenter collaborative study on the risk factors of cardiac sequelae due to Kawasaki disease: a one-year follow-up study. Acta Paediatr 89(12):1435-1438
21. Research Committee on Kawasaki Disease, Ministry of Health and Welfare, Tokyo (1984) Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease
22. Sasaguri Y, Kato H (1982) Regression of aneurysms in Kawasaki disease: a pathological study. J Pediatr 100(2):225-231
23. Shulman ST, Rowley AH (2004) Advances in Kawasaki disease. Eur J Pediatr 163(6):285-291
24. Silva AA, Maeno Y, Hashmi A, Smallhorn JF, Silverman ED, McCrindle BW (2001) Cardiovascular risk factors after Kawasaki disease: a case-control study. J Pediatr 138(3):400-405
25. Takahashi M, Mason W, Lewis AB (1987) Regression of coronary aneurysms in patients with Kawasaki syndrome. Circulation 75(2):387-394
26. de Zorzi A, Colan SD, Gauvreau K, Baker AL, Sundel RP, Newburger JW (1998) Coronary artery dimensions may be misclassified as normal in Kawasaki disease. J Pediatr 133(2):254-258